Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00522275 · ClinicalTrials.gov registry record · Phase 3
Determine Safety and Efficacy of Long-term Oral Lacosamide in Patients With Partial Seizures
A Phase 3 study, sponsored by UCB Biosciences.
- Completed
- Registry status
- Phase 3
- Development phase
- 308
- Enrollment target
NCT00522275: Completed Phase 3 study, sponsored by UCB Biosciences.
NCT00522275 is a Phase 3 study that has completed, run by UCB Biosciences. The registered enrollment target is 308 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (60% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00522275, a Phase 3 study, has completed, sponsored by UCB Biosciences.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 308 participants
- Enrollment target
Study Summary
The purpose of this trial is to determine whether lacosamide is safe and effective for long-term use in patients with partial-seizures from epilepsy
Primary Outcome
Adverse events are any untoward medical occurrences in a subject administered study treatment, whether or not these events are related to treatment.
Interventions
- DRUG lacosamide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 308 participants |
| Start Date | 2004-10 |
| Est. Completion | 2009-10 |
| Phase | Phase 3 |
What the finished NCT00522275 record still lists
NCT00522275 is an interventional study that assigns participants to a tested intervention. The registered 308 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (60% lower).
The record links to 0 conditions, and to 1 intervention - of which lacosamide is the first listed.
NCT00522275 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00522275 about?
NCT00522275 is a clinical study titled "Determine Safety and Efficacy of Long-term Oral Lacosamide in Patients With Partial Seizures". The purpose of this trial is to determine whether lacosamide is safe and effective for long-term use in patients with partial-seizures from epilepsy
What is the current status of trial NCT00522275?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 308 participants. The study started on 2004-10. Estimated completion is 2009-10.
What interventions are being tested in trial NCT00522275?
The interventions under investigation include: lacosamide (DRUG).
Who is sponsoring clinical trial NCT00522275?
This trial is sponsored by UCB Biosciences, which has 39 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00522275's enrollment target sits among peer trials
308 1112th of 2000 higher than 886 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04162938 · 308 participants · NA
Use of a Patient-Centered Electronic App to Increase ED Patient's Knowledge on HCV to Improve the HCV Care Continuum
- NCT04955795 · 308 participants · NA
Telemedicine for Unhealthy Alcohol Use in Persons Living With HIV Using CETA
- NCT06090539 · 308 participants · Phase 1
A Study to Assess BMS-986458 Alone and in Combination With Anti-lymphoma Agents in Relapsed/Refractory Non-Hodgkin Lymphomas
- NCT06233942 · 308 participants · Phase 1
Phase 1a/1b First-in-Human Study of BG-C9074 Alone and in Combination With Other Anticancer Therapies in Patients With Advanced Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia